Program
ralmitaront
Also written as “RO6889450” and “Ralmitaront”.
Its studies are mostly in Schizophrenia, led by Hoffmann-La Roche.
Furthest: phase 2, since Sep 12, 20184 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Hoffmann-La Roche | 40 open or running | phase 2since Sep 12, 2018 | Feb 23, 2016 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 23, 2016First study: phase 1 study in Healthy VolunteerFirst studyNCT02699372 · 164 enrolled · Netherlands
- Sep 12, 2018Phase 2 study in SchizophreniaNCT03669640 · 131 enrolled · United States, Japan, Spain and more
- Aug 12, 2020Phase 2 study in SchizophreniaNCT04512066 · 287 enrolled · United States, Japan, Russian Federation and more
- Mar 11, 2025Phase 1 study in SchizophreniaNCT06880328 · 35 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06880328Schizophrenia · United States | 1 | Completed | Sep 4, 2019 | 35 |
| NCT04512066Schizophrenia · United States, Japan, Russian Federation and more | 2 | Completed | Jun 21, 2022 | 287 |
| NCT03669640Schizophrenia · United States, Japan, Spain and more | 2 | Terminated | Mar 12, 2023 | 131 |
| NCT02699372Healthy Volunteer · Netherlands | 1 | Completed | Apr 14, 2017 | 164 |
How it is read
Names in the registry
- “RO6889450”, 3 entries
- “Ralmitaront”, 1 entry
Conditions, from the studies’ own filings
- Schizophrenia, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.